Since the discovery of PTPN11 mutations as the cause of Noonan syndrome in 2001, a plethora of preclinical research has been performed in order to better define the pathological mechanisms of the disease and establish potential drug targets. The gene discussed is PTPN11; the disease is Noonan syndrome.